Spain at a glance
- Population
- 49.4 million 2025
- Life expectancy at birth
- 83.9 years, 2024
- People aged 65 and over
- 21.6 % of people, 2025
- Health spending per person
- 3,107 US$ per person, 2023
- Doctors
- 4.29 per 1,000 people, 2022
Updated
Reviewed by Vidhi Upadhyay
Spain Smart Inhalers Market Industry Trends and Forecast to 2034: Segmented by (Product, Indication, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$18.3 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $4.2 Mn | — | — |
| 2025 (base) | $4.9 Mn | +$0.8 Mn | — |
| 2026 (forecast) | $5.9 Mn | +$0.9 Mn | +18.8% |
| 2027 (forecast) | $7.0 Mn | +$1.1 Mn | +41.1% |
| 2028 (forecast) | $8.3 Mn | +$1.3 Mn | +67.7% |
| 2029 (forecast) | $9.8 Mn | +$1.6 Mn | +99.2% |
| 2030 (forecast) | $11.7 Mn | +$1.8 Mn | +136.6% |
| 2031 (forecast) | $13.9 Mn | +$2.2 Mn | +181.1% |
| 2032 (forecast) | $16.5 Mn | +$2.6 Mn | +234% |
| 2033 (forecast) | $19.6 Mn | +$3.1 Mn | +296.8% |
| 2034 (forecast) | $23.3 Mn | +$3.7 Mn | +371.4% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $4.9 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $23.3 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 18.8% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, indication and end user (see all) |
| Key players | Propeller Health, Adherium, Teva Pharmaceutical, AstraZeneca, Cohero Health (see all) |
| Regulator in Spain | AEMPSSource: Spanish Agency of Medicines and Medical Devices (AEMPS). Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Smart inhalers record when and how a patient uses an inhaler and send reminders, helping control asthma and COPD.
Key segments of the smart Inhalers market include product (Inhaler Add-On Sensors and Integrated Smart Inhalers) and indication (Asthma and COPD).
Better sensors, longer battery life, smartphone apps and interest in tracking health every day are driving the smart Inhalers market. Doctors are starting to use wearable data in care decisions.
Medical-grade wearables, links to virtual care programs and insurer-funded prevention give the smart Inhalers market strong growth.
Questions about accuracy, data privacy, limited reimbursement and users who stop wearing devices hold back the smart Inhalers market.
The smart Inhalers market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices need CE marking under the EU Medical Device Regulation (MDR); AEMPS, the Spanish Agency of Medicines and Medical Devices, oversees them in Spain.[1] The National Health System (SNS), run by the regions, gives universal public care.[2]
[1] Spanish Agency of Medicines and Medical Devices (AEMPS). Checked 14 Nov 2026.
[2] Spanish Ministry of Health. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how smart Inhalers products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Spain.
What doctors and scientists are doing in Smart Inhalers right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.
From our blog
Spain · 1 shared keyword
Spain
Spain
Spain
Spain
Spain
Digital Health · Spain
Digital Health · Spain
Pharmaceuticals · Spain
Healthcare Services · Spain
Digital Health · Spain
Pharmaceuticals · Spain